This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carter, A. M. Articles by Grant, P. J. Search for Related Content PubMed PubMed Citation Articles by Carter, A. M. Articles by Grant, P. J. Pubmed/NCBI databases Substance via MeSH Related Collections Cerebrovascular disease/stroke Embolic stroke Genetics of Stroke

(Circulation. 1999;99:2423-2426.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Association of the -Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation

Angela M. Carter, PhD; Andrew J. Catto, MRCP; Peter J. Grant, MD

From the Unit of Molecular Vascular Medicine, Research School of Medicine, University of Leeds, Leeds General Infirmary, UK.

Correspondence to Peter J. Grant, Unit of Molecular Vascular Medicine, Research School of Medicine, G Floor, Martin Wing, Leeds General Infirmary, Leeds, LS1 3EX, UK. E-mail p.j.grant{at}leeds.ac.uk

Background—The -fibrinogen Thr312Ala polymorphism occurs in close proximity to several sites important for factor XIIIa–dependent cross-linking, which raises the possibility that it affects fibrin clot stability.

Methods and Results—We determined the association of this polymorphism with ischemic stroke, stroke subtype, and poststroke mortality. There was no significant difference in the genotype distributions of patients with acute ischemic stroke (n=519) and healthy control subjects (n=423), nor was there any association of this polymorphism with stroke subtype. In a Cox regression model, a significant interaction between Thr312Ala and atrial fibrillation was identified in relation to poststroke mortality (P=0.002). In subjects in sinus rhythm (n=418), there was no difference according to genotype in the proportion of subjects who survived (60% in each group), whereas in subjects with atrial fibrillation (n=101), there was decreased survival in those possessing the A allele (TT=42.1%, TA=18%, AA=0%).

Conclusions—The Thr312Ala polymorphism may give rise to an increased susceptibility for embolization of intra-atrial clot, and these findings could have important implications for identifying subjects most at risk of developing thromboembolic complications.

Key Words: stroke • mortality • atrial fibrillation

This article has been cited by other articles:

				M van Oijen, E Y L Cheung, C E M Geluk, A Hofman, P J Koudstaal, M M B Breteler, and M P de Maat Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 799 - 803. [Abstract] [Full Text] [PDF]

				J. Suntharalingam, K. Goldsmith, V. van Marion, L. Long, C. M. Treacy, F. Dudbridge, M. R. Toshner, J. Pepke-Zaba, J. C. J. Eikenboom, and N. W. Morrell Fibrinogen A{alpha} Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Eur. Respir. J., April 1, 2008; 31(4): 736 - 741. [Abstract] [Full Text] [PDF]

				A. M. Carter, A. J. Catto, M. W. Mansfield, J. M. Bamford, and P. J. Grant Predictive Variables for Mortality After Acute Ischemic Stroke Stroke, June 1, 2007; 38(6): 1873 - 1880. [Abstract] [Full Text] [PDF]

				G. G. Leblanc, J. F. Meschia, D. T. Stuss, and V. Hachinski Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges Stroke, January 1, 2006; 37(1): 248 - 255. [Abstract] [Full Text] [PDF]

				J. F. Meschia Clinically Translated Ischemic Stroke Genomics Stroke, November 1, 2004; 35(11_suppl_1): 2735 - 2739. [Abstract] [Full Text] [PDF]

				E. M. Scott, R. A.S. Ariens, and P. J. Grant Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1558 - 1566. [Abstract] [Full Text] [PDF]

				B. Voetsch and J. Loscalzo Genetic Determinants of Arterial Thrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 216 - 229. [Abstract] [Full Text]

				S. Kamath and G.Y.H. Lip Fibrinogen: biochemistry, epidemiology and determinants QJM, October 1, 2003; 96(10): 711 - 729. [Full Text] [PDF]

				J. D. Mills, R. A.S. Ariens, M. W. Mansfield, and P. J. Grant Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease Circulation, October 8, 2002; 106(15): 1938 - 1942. [Abstract] [Full Text] [PDF]

				R. A. S. Ariens, T.-S. Lai, J. W. Weisel, C. S. Greenberg, and P. J. Grant Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms Blood, July 18, 2002; 100(3): 743 - 754. [Abstract] [Full Text] [PDF]

				A. J. Catto Genetic aspects of the hemostatic system in cerebrovascular disease Neurology, September 1, 2001; 57(90002): S24 - 30. [Abstract] [Full Text]

				S.-L. Zhang, W. DuBois, E. S. Ramsay, V. Bliskovski, H. C. Morse III, L. Taddesse-Heath, W. C. Vass, R. A. DePinho, and B. A. Mock Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility Mol. Cell. Biol., January 1, 2001; 21(1): 310 - 318. [Abstract] [Full Text]

				A. M. Carter, A. J. Catto, H. P. Kohler, R. A. S. Ariens, M. H. Stickland, and P. J. Grant alpha -Fibrinogen Thr312Ala polymorphism and venous thromboembolism Blood, August 1, 2000; 96(3): 1177 - 1179. [Abstract] [Full Text] [PDF]

				D. A. Lane and P. J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood, March 1, 2000; 95(5): 1517 - 1532. [Full Text] [PDF]